September 17, 2021 It’s time to get your flu shot, learn more about the seasonal influenza vaccine here. 1. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use Palache et al., Vaccine / September 11, 2021 The International Federation of Pharmaceutical Manufacturers and Associations’ (IFPMA) Influenza Vaccine Supply International Task Force conducted an updated seasonal influenza vaccine allocation survey. While…

August 20, 2021 1. Seqirus Announces Investment in Next-Generation Influenza Vaccine Technology, Self-Amplifying Messenger RNA (sa-mRNA) PRNewswire / August 19, 2021 This week, Sequris announced the creation of a program dedicated to the development of self-amplifying mRNA (sa-mRNA) vaccines. sa-mRNA vaccine technology includes genetic instructions to not only produce viral protein, but to also produce a polymerase to further replicate the protein many…

August 13, 2021 1. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains Skarlupka et al., Journal of Virology / August 10, 2021 While the primary target antigen for many influenza vaccines is the hemagglutinin (HA) surface protein, the neuraminidase (NA) surface protein has a slower evolutionary rate, “crossing” more HA subtypes, making it a potential target in the design…

August 6, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges.

July 30, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. Co-circulation of multiple influenza A reassortants in 2 swine harboring genes from seasonal human and swine 3 influenza viruses

July 23, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. Nasal-Spray Combined Vaccine for Covid and Flu Shows Protection Outbreak News…

July 16, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus Lee et…

July 9, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. Influenza virus infection expands the breadth of antibody responses through IL-4 signaling in B cells

July 2, 2021 Conference Announcement: The Eighth ESWI Influenza Conference is December 4th to 7th, 2021. Join colleagues and peers from around the world in Salzburg for the largest conference dedicated to influenza, RSV disease and Covid-19. Register here. Abstracts are due September 3, 2021; submit abstracts here. 1. The Added Value of Vaccination Seth Berkley…